Status:
UNKNOWN
Regulation of Amygdala Via Neurofeedback in PTSD After Childhood Sexual Abuse
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Collaborating Sponsors:
Tel Aviv University
Conditions:
PTSD
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Post-traumatic stress disorder (PTSD) is a common debilitating disorder that affects many individuals exposed to aversive events. The severity of PTSD symptoms is positively correlated with amygdala a...
Detailed Description
Pretreatment phase- All participants will undergo clinician evaluation and self-report measures in TASMC. In addition, they will receive a WatchPAT (wearable technology) for tracking sleep for 2 night...
Eligibility Criteria
Inclusion
- Treated at Clinic for Sexual Assault with stable symptoms. Fulfill screening criteria of DSM-V for PTSD.
- \-
Exclusion
- Fulfill screening criteria of DSM-V for psychosis. Substance dependence or abuse other than nicotine. Diagnosis of a neurodegenerative disease. Acute illness that could be worsen by the treatment. -
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04303533
Start Date
August 1 2020
End Date
December 1 2021
Last Update
March 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.